Skip to content

Immersive Virtual Reality for Cognitive Rehabilitation in Stroke Patients: Study Protocol for a Randomized Controlled Trial

Immersive Virtual Reality for Cognitive Rehabilitation in Stroke Patients: Study Protocol for a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116040
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control Group:Routine cognitive training consists of paper-and-pencil or computer-based tasks, covering various training methods targeting memory, computational ability, attention, apraxia, and other
Experimental Group:On the basis of conventional intervention, additional immersive virtual reality (VR) training is provided, including immersive scenario training, motor perception training, memory s

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.First episode of unilateral ischemic or hemorrhagic stroke confirmed by MRI or CT, in accordance with the definition of the World Health Organization (WHO). 2.Aged 18 to 70 years, with no gender restriction. 3.The time of first onset ranges from March to June. 4.Score on the Montreal Cognitive Assessment (MoCA) ranging from 18 to 25 points, indicating mild cognitive impairment. 5.No severe visual or auditory impairment, or with mild visual/auditory impairment that does not affect cooperation in completing VR training. 6.Voluntary participation in the study and provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1 .Exclude patients with sensory or motor dysfunction that may interfere with VR intervention. 2. Intolerance to virtual reality equipment (e.g., motion sickness, history of epilepsy). 3 .Presence of contraindications to fMRI or EEG examinations (e.g., cardiac pacemaker, intracranial metallic foreign bodies, skin infection, etc.). 4. A history of cognitive impairment caused by mental illness, neurological diseases, internal medical conditions, or substance abuse. 5 .Special physiological status: pregnant or lactating women.4.6 Concurrent participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Mini-Mental State Examination, MMSE;Stroop Color and Word Test, SCWT;Logical Memory Test, LMT;Symbol Digit Modalities Test, SDMT;Trail Making Test, TMT ;Hamilton Anxiety Scale, HAMA;Hamilton Depression Scale, HAMD;Functional Magnetic Resonance Imaging, fMRI;Electroencephalogram, EEG;

Countries

China

Contacts

Public ContactHua Xuyun

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

huaxuyun@shutcm.edu.cn+86 189 1612 0869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026